Ken Griffin’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.23M Sell
30,800
-5,100
-14% -$395K ﹤0.01% 6480
2026
Q2
$2.46M Sell
35,900
-6,600
-16% -$375K ﹤0.01% 6095
2026
Q1
$2.73M Sell
42,500
-29,000
-41% -$2.64M ﹤0.01% 5448
2025
Q4
$9.3M Hold
71,500
– – ﹤0.01% 3351
2025
Q3
$7.7M Sell
71,500
-8,200
-10% -$893K ﹤0.01% 3633
2025
Q2
$7.36M Buy
79,700
+21,200
+36% +$1.66M ﹤0.01% 3477
2025
Q1
$5.18M Buy
58,500
+9,200
+19% +$798K ﹤0.01% 3811
2024
Q4
$3.79M Sell
49,300
-7,300
-13% -$510K ﹤0.01% 4428
2024
Q3
$2.4M Buy
56,600
+9,800
+21% +$331K ﹤0.01% 5184
2024
Q2
$1.22M Buy
46,800
+1,600
+4% +$30.3K ﹤0.01% 6205
2024
Q1
$413K Buy
+45,200
New +$271K ﹤0.01% 8804
2023
Q4
– Sell
-1,000
Closed -$3.64K – 15357
2023
Q3
$3.64K Sell
1,000
-776
-44% -$4.25K ﹤0.01% 13564
2023
Q2
$10.6K Buy
1,776
+424
+31% +$3.36K ﹤0.01% 13196
2023
Q1
$16.3K Buy
1,352
+140
+12% +$1.87K ﹤0.01% 13213
2022
Q4
$10.6K Buy
1,212
+779
+180% +$17.2K ﹤0.01% 13614
2022
Q3
$13K Buy
+433
New +$19.8K ﹤0.01% 12209
2022
Q2
– Sell
-394
Closed -$40K – 14228
2022
Q1
$40K Sell
394
-721
-65% -$80.1K ﹤0.01% 12942
2021
Q4
$164K Sell
1,115
-488
-30% -$109K ﹤0.01% 12150
2021
Q3
$402K Sell
1,603
-1,227
-43% -$421K ﹤0.01% 10401
2021
Q2
$1.31M Buy
2,830
+1,060
+60% +$455K ﹤0.01% 7652
2021
Q1
$870K Buy
+1,770
New +$920K ﹤0.01% 8444

Other funds holding WGS

Ken Griffin's WGS Position: Q3 2026 in Review

Ken Griffin reduced its GeneDx Holdings (WGS) stake by 23% in Q3 2026, selling an estimated $15.2M and leaving 668,709 shares worth $48.3M. The position accounts for 0.01% of the portfolio, ranked #1584.

Ken Griffin first reported a position in WGS in Q1 2021 and has held it in 21 quarters since. The position peaked at $59.4M in Q2 2026. 219 funds tracked by Wall St. Rank hold WGS as of Q3 2026.

  • Ken Griffin held 668,709 shares of GeneDx Holdings worth $48.3M as of Q3 2026.
  • Ken Griffin sold 196,753 GeneDx Holdings shares in Q3 2026, an estimated $15.2M.
  • GeneDx Holdings made up 0.01% of Ken Griffin's portfolio in Q3 2026, its #1584 holding.
  • Ken Griffin first reported a position in GeneDx Holdings in Q1 2021 and has held it in 21 quarters since.
  • Ken Griffin's GeneDx Holdings position peaked at $59.4M in Q2 2026.
  • 219 funds tracked by Wall St. Rank held GeneDx Holdings as of Q3 2026.

Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.